Outsourcing Directory


G-M-I Inc.





Company Headquarters

4822 East 355th Street
Willoughby, OH 44094-4634
United States

Outsourcing Directory

    Related Content

    • Cardiovascular
      Medtronic to Pay $51 Million to Resolve Claims Against Acquired Units

      Medtronic to Pay $51 Million to Resolve Claims Against Acquired Units

      The company is settling three claims against Covidien LP and ev3 Inc.
      Medtronic 12.06.18

    • R&D & Design
      MedTech Innovator Opens Applications for 2019 Competition

      MedTech Innovator Opens Applications for 2019 Competition

      The 2019 showcase to feature industry’s 50 best-in-class medical technology startups.
      MedTech Innovator 12.03.18

    • RSNA News: Canon Medical Launches New Premium MR System: Vantage Orian 1.5T

      RSNA News: Canon Medical Launches New Premium MR System: Vantage Orian 1.5T

      New system features help improve workflow and deliver clinical confidence.
      Business Wire 11.27.18


    • Cardiovascular | Surgical
      Merit Medical Buys Cianna Medical for Up to $200M

      Merit Medical Buys Cianna Medical for Up to $200M

      Cianna Medical is a leader in wire-free breast localization and has been focused on breast conservation for 11 years.
      GlobeNewswire 10.02.18

    • Reprieve Cardiovascular Debuts at Heart Failure 2018

      Reprieve Cardiovascular Debuts at Heart Failure 2018

      Showcased guided diuretic therapy in development for the optimization of fluid management for patients with heart failure.
      Business Wire 09.18.18

    • Cardiovascular | Surgical
      Boston Scientific to Acquire VENITI for $108M

      Boston Scientific to Acquire VENITI for $108M

      Acquisition to bolster company's Venous Therapies portfolio within Peripheral Interventions Division.
      PR Newswire 08.08.18


    • Cardiovascular | Digital Health | Patient Monitoring
      Mobile Health Devices Diagnose Hidden Heart Condition in At-Risk Populations

      Mobile Health Devices Diagnose Hidden Heart Condition in At-Risk Populations

      Scientists use digital medicine technologies to identify undiagnosed atrial fibrillation in at-risk populations.
      Scripps Research Institute 07.11.18

    • Diagnostics
      Bio-Techne Buys Exosome Diagnostics for Up to $575M

      Bio-Techne Buys Exosome Diagnostics for Up to $575M

      Currently Exosome Diagnostics markets a urine-based test to assist physicians in determining the need for a prostate biopsy.
      PR Newswire 06.27.18